Management and outcome of clinically evident neck recurrence in patients with papillary thyroid cancer.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28516448)

Published in Clin Endocrinol (Oxf) on May 18, 2017

Authors

Laura Y Wang1, Jocelyn C Migliacci1, R Michael Tuttle2, Ashok R Shaha1, Jatin P Shah1, Snehal G Patel1, Ian Ganly1

Author Affiliations

1: Department of Surgery, Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
2: Department of Medicine, Endocrine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Articles cited by this

Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med (1994) 8.39

Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab (2001) 4.73

The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid (2012) 1.82

The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation. J Clin Endocrinol Metab (2011) 1.74

Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer. J Clin Endocrinol Metab (2010) 1.65

Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131) Ann Surg (1994) 1.21

Papillary thyroid cancer: time course of recurrences during postsurgery surveillance. J Clin Endocrinol Metab (2013) 1.16

Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer. Laryngoscope (2008) 1.08

Effect of reoperation on outcomes in papillary thyroid cancer. Surgery (2013) 1.04

Reoperative experience with papillary thyroid cancer. World J Surg (2014) 1.00

Update in utility of secondary node dissection for papillary thyroid cancer. J Clin Endocrinol Metab (2012) 0.89

Management of recurrent and persistent metastatic lymph nodes in well-differentiated thyroid cancer: a multifactorial decision-making guide for the thyroid cancer care collaborative. Head Neck (2014) 0.88

Prognosis of patients with papillary thyroid carcinoma showing postoperative recurrence to the central neck. World J Surg (2011) 0.86

Efficacy and safety of central compartment neck dissection for recurrent thyroid carcinoma. Arch Otolaryngol Head Neck Surg (2012) 0.82

Management of recurrent/persistent nodal disease in patients with differentiated thyroid cancer: a critical review of the risks and benefits of surgical intervention versus active surveillance. Thyroid (2015) 0.80

Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma. Thyroid (2011) 0.79

Iodine-131 radio-guided surgery in differentiated thyroid cancer: outcome on 31 patients and review of the literature. Biomed Pharmacother (2007) 0.79

Impact of initial surgical treatment on survival of patients with differentiated thyroid cancer: experience of an endocrine surgery center in an iodine-deficient region. World J Surg (2000) 0.79

Articles by these authors

Role of RAI in the management of incidental N1a disease in papillary thyroid cancer. Clin Endocrinol (Oxf) (2015) 0.78